Please enable Javascript
Julien Calderaro, MD, PhD
Julien Calderaro, MD, PhD
Articles by Julien Calderaro, MD, PhD
AI as a Biomarker for ABRS in Patients With HCC
Julien Calderaro, MD, PhD
Hepatocellular Carcinoma
|
March 13, 2025
Dr. Julien Calderaro explains the potential of AI to serve as a biomarker of sensitivity to atezolizumab plus bevacizumab.
View More